ALLMedicine™ Coronary Heart Disease Center

Dec 2nd, 2020 - Background Anacetrapib is the only cholesteryl ester transfer protein inhibitor proven to reduce coronary heart disease (CHD). However, its effects on reverse cholesterol transport have not been fully elucidated. Macrophage cholesterol efflux (CEC...

Dec 2nd, 2020 - The Seattle Angina Questionnaire (SAQ) is a widely-used patient-reported outcomes measure in patients with heart disease. This study assesses the validity and reliability of the SAQ in a Canadian cohort of individuals with stable angina. Data are ...

Dec 1st, 2020 - Matrix Gla protein (MGP) is a natural inhibitor of vascular calcification critically dependent on circulating vitamin K status. Growth differentiation factor 15 (GDF-15) is a regulatory cytokine mainly of the inflammatory and angiogenesis pathways...

Dec 1st, 2020 - FOXO3 is a prominent longevity gene. To date, no-one has examined whether longevity-associated FOXO3 genetic variants protect against mortality in all individuals, or only in those with aging-related diseases. We therefore tested longevity-associa...

Nov 30th, 2020 - Coronary heart disease (CHD) is one of the leading causes of mortality worldwide. Previous research has demonstrated that resourcefulness interventions can help individuals identify effective coping strategies to manage their conditions, reduce th...

Jul 8th, 2019 - Background: The role of nutritional supplements and dietary interventions in preventing mortality and cardiovascular disease (CVD) outcomes is unclear. Purpose: To examine evidence about the effects of nutritional supplements and dietary interven...

Feb 28th, 2017 - The aim of this study was to identify the prevalence of metabolic syndrome (MetS) and degree of cardiovascular disease (CVD) risk in patients with psoriatic arthritis (PsA). Material and Methods We performed a cross-sectional study on 102 adult p...

Sep 28th, 2015 - As nutrition-related chronic diseases have become more and more frequent, the importance of dietary prevention has also increased. Dietary fat plays a major role in human nutrition, and modification of fat and/or fatty acid intake could have a pre...

Jul 25th, 2014 - A large body of empirical research shows that psychosocial risk factors (PSRFs) such as low socio-economic status, social isolation, stress, type-D personality, depression and anxiety increase the risk of incident coronary heart disease (CHD) and ...

Jul 31st, 2012 - Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for coronary heart disease (CHD). The USPSTF reviewed new evidence on the benefits of screening with electrocardiography (ECG) in asymptomatic ad...

Dec 2nd, 2020 - Background Anacetrapib is the only cholesteryl ester transfer protein inhibitor proven to reduce coronary heart disease (CHD). However, its effects on reverse cholesterol transport have not been fully elucidated. Macrophage cholesterol efflux (CEC...

Dec 2nd, 2020 - The Seattle Angina Questionnaire (SAQ) is a widely-used patient-reported outcomes measure in patients with heart disease. This study assesses the validity and reliability of the SAQ in a Canadian cohort of individuals with stable angina. Data are ...

Dec 1st, 2020 - Matrix Gla protein (MGP) is a natural inhibitor of vascular calcification critically dependent on circulating vitamin K status. Growth differentiation factor 15 (GDF-15) is a regulatory cytokine mainly of the inflammatory and angiogenesis pathways...

Dec 1st, 2020 - FOXO3 is a prominent longevity gene. To date, no-one has examined whether longevity-associated FOXO3 genetic variants protect against mortality in all individuals, or only in those with aging-related diseases. We therefore tested longevity-associa...

Nov 30th, 2020 - Coronary heart disease (CHD) is one of the leading causes of mortality worldwide. Previous research has demonstrated that resourcefulness interventions can help individuals identify effective coping strategies to manage their conditions, reduce th...

Oct 6th, 2020 - Women are known to lag 5 to 10 years behind men in experiencing coronary heart disease (CHD), but new research suggests the gap narrows substantially following a myocardial infarction (MI). "Women lose a considerable portion, but not all, of their...

Oct 6th, 2020 - Women are known to lag 5 to 10 years behind men in experiencing coronary heart disease (CHD), but new research suggests the gap narrows substantially following a myocardial infarction (MI). "Women lose a considerable portion, but not all, of their...

Sep 24th, 2020 - NEW YORK (Reuters Health) - Recurrent coronary heart disease (CHD) events declined for both men and women from 2008 to 2017, with a greater proportional decline for women, according to new findings from the U.S. "Despite the decline seen in this s...

Aug 27th, 2020 - NEW YORK (Reuters Health) - Being positive for factor V Leiden (FVL) does not increase the risk of atherothrombotic events and mortality in patients with coronary heart disease (CHD), according to a meta-analysis of data from the GENIUS-CHD consor...

Jul 15th, 2020 - Takeaway The incidence of myocardial infarction (MI) was higher in men than women, but the presence of diabetes was associated with a greater excess relative risk of myocardial infarction (MI) in women than men. Each 1% higher glycated haemoglobin...